From: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer
Analysis | Parameter | DFS | OS | ||||
---|---|---|---|---|---|---|---|
HRa (95%CI) | Log-rank p-value | Bivariate interaction p-value | HRa (95%CI) | Log-rank p-value | Bivariate interaction p-value | ||
Overall | |||||||
TGIF moderate/strong | 0.75 (0.59–0.95) | 0.019 | – | 0.69 (0.51–0.94) | 0.018 | – | |
Subgroups | |||||||
iddEPC | moderate/strong TGIF | 0.70 (0.50–0.98) | 0.036 | 0.575 | 0.69 (0.45–1.07) | 0.095 | 0.978 |
ddEC-PwX | moderate/strong TGIF | 0.81 (0.58–1.14) | 0.228 | 0.69 (0.45–1.08) | 0.105 | ||
Ibandronate treatment | moderate/strong TGIF | 0.79 (0.59–1.07) | 0.131 | 0.620 | 0.72 (0.49–1.06) | 0.094 | 0.729 |
without Ibandronate treatment | moderate/strong TGIF | 0.68 (0.46–1.01) | 0.057 | 0.64 (0.38–1.07) | 0.087 | ||
ER-negative | moderate/strong TGIF | 1.03 (0.67–1.58) | 0.893 | 0.130 | 1.02 (0.60–1.75) | 0.933 | 0.107 |
ER-positive | moderate/strong TGIF | 0.68 (0.51–0.91) | 0.009 | 0.60 (0.41–0.88) | 0.008 | ||
HER2-negative | moderate/strong TGIF | 0.67 (0.50–0.88) | 0.004 | 0.034 | 0.57 (0.40–0.82) | 0.002 | 0.015 |
HER2-positive | moderate/strong TGIF | 1.27 (0.75–2.18) | 0.375 | 1.79 (0.80–4.00) | 0.151 | ||
TNBC | moderate/strong TGIF | 1.00 (0.57–1.75) | 0.995 | 0.427 | 1.05 (0.56–1.96) | 0.876 | 0.291 |
non-TNBC | moderate/strong TGIF | 0.76 (0.58–1.00) | 0.049 | 0.70 (0.48–1.01) | 0.055 |